This is consistent with the pro-survival properties attributed to PKCδ in tumor models, including known roles for PKCδ in invasion and migration [11, 29-31], and our own data that shows increased PKCδ expression correlates with a worse prognosis in breast cancer patients [6, 12]. Here, PRKCD is linked to neoplasm.